secwatch.observer — SEC 8-K summary
======================================

Issuer:     IDEXX LABORATORIES INC /DE (IDXX)
CIK:        0000874716
Form:       8-K
Filed at:   2026-03-26T23:59:59+00:00
Accession:  0001104659-26-034906
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IDEXX EVP Nimrata Hunt to depart Apr 13; position eliminated, advisory role until Jul 13
--------------------------------------------------------------------------------

- Nimrata Hunt, EVP Global Strategy & Commercial, steps down effective Apr 13, 2026; position eliminated.
- Advisory role from Apr 13 to Jul 13, 2026; per diem pay based on current base salary.
- Separation benefits: $1.23M salary continuation (104 weeks), $984K bonus (2 years), plus COBRA; ~$2.29M total.
- All unvested equity awards forfeited as of Jul 13; vested options remain exercisable per award terms.
- No successor named; restructuring of global strategy & commercial function.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874716/000110465926034906/0001104659-26-034906-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874716/000110465926034906/tm269826d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-034906

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer